SCHEMBL21840283

SCHEMBL21840283

CC(CO[Si](C)(C)C(C)(C)C)c1cc(Oc2c(Cl)cc(I)cc2Cl)nnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21749424 0.89 MAPT (0.33)
SCHEMBL32675678 0.89 MAPT (0.33)
SCHEMBL21840282 0.81 THRA (0.33)
SCHEMBL21840329 0.78 THRA (0.38)
SCHEMBL29417446 0.78 THRA (0.38)
SCHEMBL21840375 0.77 THRA (0.40)
SCHEMBL21749353 0.77 LMNA (0.30)
SCHEMBL21840379 0.74 CRHR1 (0.32)
SCHEMBL21840377 0.69 THRA (0.33)
SCHEMBL38660709 0.69 THRA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220348561-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS TERNS PHARMACEUTICALS INC (US) 2022-11-03 US disclosed
US-11203587-B2 Thyroid hormone receptor beta agonist compounds Terns, Inc. (US) 2021-12-21 US disclosed
US-11203587-B2 Thyroid hormone receptor beta agonist compounds Terns, Inc. (US) 2021-12-21 US disclosed
EP-3863635-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. (US) 2021-08-18 EP disclosed
CN-112839655-A Thyroid hormone receptor beta agonist compounds 拓臻股份有限公司 2021-05-25 CN disclosed
US-20200115362-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS TERNS PHARMACEUTICALS, INC. (KY) 2020-04-16 US disclosed
US-20200115362-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS TERNS PHARMACEUTICALS, INC. (KY) 2020-04-16 US disclosed